MIP Search | Managing Intellectual Property

TK debate puts pressure on patentees

Spurred on by success in several cases, campaigners in developing countries want to reform the patent system to recognize the place of traditional knowledge. If change comes, it will have a big impact on all patent applicants in the life sciences industry. James Nurton and Emma Barraclough report

Managing IP Correspondent, May 31 2005

What to know before investing in life sciences

By their nature, life science companies are among the more IP-dependent businesses in the corporate world. Any transactions, therefore, will require a more thorough due diligence than is the norm. Paul M Booth and Leslie Mooi outline 10 things you should know about such a company before deciding to invest in, or acquire, it

Managing IP Correspondent, May 31 2005

I can't get no satisfaction

I've been working as an advertising industry lawyer in many countries around the world for about 15 years now. I must have seen every possible approach from the creative team to try to deliver on the music that a particular client will want for a TV commercial. So far as the Middle East is concerned, I'm afraid I'd say that we have a worse attitude to copyright clearance than I've seen in any other region.

Managing IP Correspondent, May 31 2005

SPCs for formulation patents

According to Regulation 1768/92/EEC supplementary protection certificates (SPCs) can be granted for novel medicines. They are intended to compensate for the reduced effective lifetime of patents covering such medicines.

Managing IP Correspondent, May 31 2005

Choosing the right search and examination option

The Singapore Patents Act was amended on July 1 2004. The amendments have brought about various changes to the search and examination options available to applicants using the PCT route. The options available for applications with filing dates both before and after July 1 2004 are outlined below.

Managing IP Correspondent, May 31 2005

India's unfinished TRIPs agenda

India's Minister for Commerce & Industry has formed a Technical Expert Committee to study two critical issues that Parliament did not consider when it passed the Patents (Amendment) Act 2005. The Expert Committee has been asked to consider the patentability of new chemical entities and micro-organisms. If it suggests that amendments should be made to the law in relation to these two areas, changes will be incorporated into the new legislation.

Managing IP Correspondent, May 31 2005

How to bring a criminal action in China

New rules on criminal thresholds should make it easier for prosecutors to bring charges against IP infringers. But as the authorities struggle to manage a mounting workload, IP owners should consider taking the law into their own hands and launching private criminal prosecutions, explains Gordon Gao

Managing IP Correspondent, May 31 2005

Beware the transfer pricing trap

On their face, transfer prices can have dangerous implications for potential damages claims in infringement cases. Phillip Beutel, Bryan Ray and Steven Schwartz outline what in-house counsel need to know to avoid pitfalls

Managing IP Correspondent, May 31 2005

A year of change for pharma companies

The past year has seen important changes in the EU. It grew from 15 member states to 25 and, for the pharmaceutical industry, many new laws entered into force, were enacted, or were proposed. Linda Horton reviews the developments

Managing IP Correspondent, May 31 2005

China clarifies policy on domain name disputes

On March 1 2005, the China Internet Network Information Center (CNNIC) issued an interpretation on its Domain Name Dispute Resolution Policy (the Interpretation) to clarify three definitions. The Interpretation took immediate effect.

Managing IP Correspondent, May 31 2005

Search results for